Browse Studies — Arctuva

Observational

One-Day cTBS Over the Precuneus (OcTOPUS)

The goal of this clinical trial is to learn whether two forms of one-day accelerated transcranial magnetic stimulation (TMS) can reduce depressive symptoms in …

Depressive Disorder, Treatment-ResistantTreatment Resistant Depression (TRD)Treatment Resistant Major Depression Disorder

Estimated

~$10 – $6,250

Mclean HospitalNCT07758010

Comparative Effectiveness of Racemic Ketamine Versus Esketamine (Spravato®) for Depression: The OBSERVE Protocol

This observational protocol is intended to provide long-term follow-up data on patients initiating or continuing treatment with either Spravato® or IV ketamine…

Major Depression Disorder

Estimated

~$10 – $750

Yale UniversityNCT06725277

Phase 1

Phase 1 Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans

The goal of this phase 1 study is to investigate the safety and efficacy of dimethyltryptamine (DMT) in individuals with depression and healthy controls. We hy…

Major Depression DisorderDepression

Estimated

~$10 – $7,500

Deepak C. D'SouzaNCT06671977

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms.

The purpose of this study is to evaluate QbMobile's ability to collect objective data to identify specific symptom profiles in differential diagnoses (ASD, MDD…

Bi-Polar DisorderAutism Spectrum Disorder (ASD)Major Depression Disorders+3 more

Estimated

~$10 – $1,125

Qbtech ABNCT07329673